SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL

Overview

SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL is an active pharmaceutical ingredient (API) supplier with 13 active FDA Type II Drug Master Files, covering ATENOLOL; BUPIVACAINE HYDROCHLORIDE; CLONIDINE BASE; CLONIDINE HCL; DIPYRIDAMOLE; GEIBROZIL.

API / Drug Master Files

SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL holds 13 active (18 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• KETOPROFENActive2006-05-23
• LIDOCAINE BASEActive2005-04-29
• CLONIDINE BASEActive1998-02-09
• TICLOPIDINE HYDROCHLORIDEActive1993-09-15
• GEIBROZILActive1991-04-05
• ATENOLOLActive1987-05-05
• BUPIVACAINE HYDROCHLORIDEActive1986-05-23
• METOPROLOL TARTRATEActive1984-11-09
• MEPIVACAINE HClActive1983-11-24
• TETRAHYDROZOLINE HClActive1983-10-28
• CLONIDINE HCLActive1982-04-05
• LIDOCAINE BASE CRYSTALLIZED & LIDOCAINE HcLActive1981-03-27
• DIPYRIDAMOLEActive1978-04-17
• PIRFENIDONEInactive1983-11-24
• HYDRALAZINE CHLORIDRATEInactive1983-06-30

Showing 15 of 18 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL in our records. PharmaTek screens the full directory against live FDA enforcement data.